Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
92.5M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
9.23M
-
Shares change
-
-2.93M
-
Total reported value, excl. options
-
$17M
-
Value change
-
-$32.7M
-
Number of buys
-
7
-
Number of sells
-
-17
-
Price
-
$1.84
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q1 2020
26 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share as of Q1 2020.
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.23M shares
of 92.5M outstanding shares and own 9.98% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.32M shares), Novo Holdings A/S (2.08M shares), BOXER CAPITAL, LLC (1.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (585K shares), Invesco Ltd. (320K shares), Tekla Capital Management LLC (213K shares), Ghost Tree Capital, LLC (209K shares), MILLENNIUM MANAGEMENT LLC (192K shares), SPHERA FUNDS MANAGEMENT LTD. (68K shares), and MORGAN STANLEY (45.2K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.